Menu

Education onlyLivozo does not offer this treatment. This page explains the topic. There is no intake, purchase or prescription path.

PT-141 (bremelanotide): what it is, what the evidence says and why Livozo does not offer it.

PT-141 is another name for bremelanotide, a peptide studied for low sexual desire. This page is education only. Livozo does not offer PT-141.

  • Education only
  • Not offered

FDA status. An FDA-approved bremelanotide product exists for a narrow use in premenopausal women. Compounded "PT-141" is not that product and is not FDA-approved.

01

What it is.

Bremelanotide acts on melanocortin receptors in the brain. In 2019, FDA approved a bremelanotide injection for premenopausal women with acquired, generalized hypoactive sexual desire disorder (low desire that causes distress).[1]

The approved product is not indicated for postmenopausal women or for men, and it is not indicated to enhance sexual performance.[1]

Products sold as compounded PT-141 are not the approved product. Compounded drugs are not FDA-approved and are not reviewed by FDA before they are marketed.[2]

02

What clinicians consider.

A licensed clinician looks at your full picture before deciding anything. These are the kinds of questions they ask. They are not a diagnosis.

  • Whether low desire is causing distress, and possible causes such as medicines, mood or relationship factors
  • Blood pressure and heart health
  • Menopause status
  • Other medicines you take
03

What the evidence says.

An FDA-approved bremelanotide product exists for a narrow use in premenopausal women. Compounded "PT-141" is not that product and is not FDA-approved.

The approved bremelanotide product was studied in premenopausal women with low sexual desire. Its label limits use to that group.[1]

Limits. Evidence for the approved product applies only to premenopausal women with this diagnosis. It does not show benefit for men, for postmenopausal women, or for compounded PT-141.

04

Risks and when to get help.

The approved label warns that bremelanotide briefly raises blood pressure and lowers heart rate after each dose. It should not be used by people with uncontrolled high blood pressure or known heart disease.[1]

Nausea was reported by 40% of patients in the label's studies. Darkening of patches of skin was reported by 1%, and is more likely with frequent doses.[1]

Tell a clinician if

  • Tell a clinician if you have high blood pressure or heart disease.
  • Tell a clinician about all medicines you take.
  • Tell a clinician if you are pregnant or could become pregnant.

Get urgent care if

  • Chest pain or pressure
  • Severe headache, confusion, or vision changes
  • Fainting or a very slow heartbeat
  • Swelling of the face, lips, tongue or throat, or trouble breathing
05

What this page covers.

  • What PT-141 and bremelanotide are
  • How the FDA-approved product differs from compounded PT-141
  • What the approved label says about who it is for and its risks
  • Why Livozo does not offer PT-141

What Livozo does not do

  • Livozo does not sell, prescribe or ship PT-141.
  • Livozo has no intake, checkout or clinician referral for PT-141.
  • Livozo does not diagnose or give personal medical advice on this page.
  • Livozo does not sell research-use-only products.
06

Cost.

Price not yet available. Livozo does not offer PT-141 and has no price for it.

Questions to ask any provider

  • Livozo does not offer PT-141, so there is no Livozo price.
  • If another provider quotes a price, ask whether the product is FDA-approved or compounded.
  • Ask which licensed pharmacy makes it and whether it is made for injection or for skin.
  • Products sold online as "research use only" are not medicines for people, at any price.
07

Availability.

Education only. Livozo does not offer PT-141. There is no intake, purchase or prescription path for it on this site, now or at launch.

Review and sources.

Written by
Livozo Editorial
Medical review
TODO(clinical) Reviewer pending. See review status
Published
Last updated
Next review
Set at clinical sign-off
  1. FDA prescribing information — bremelanotide injection (NDA 210557), 2019
  2. FDA — Human drug compounding

Questions about PT-141 (sexual health).

Is PT-141 FDA-approved?
An FDA-approved bremelanotide injection exists for premenopausal women with a specific diagnosis. Compounded PT-141 is not FDA-approved.
Does PT-141 work for men?
The approved product is not indicated for men. It is also not indicated to enhance sexual performance.
Can I get PT-141 from Livozo?
No. Livozo does not offer PT-141, and there is no intake or prescription path for it.
What are the main side effects?
The approved label lists nausea, a brief rise in blood pressure, and darkening of skin patches. People with uncontrolled high blood pressure or heart disease should not use it.

Keep reading.